Robert Barrow
2023
In 2023, Robert Barrow earned a total compensation of $2.1M as Chief Executive Officer at Mind Medicine (MindMed), a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,725 |
|---|---|
| Salary | $598,750 |
| Stock Awards | $1,212,000 |
| Other | $13,658 |
| Total | $2,143,133 |
Barrow received $1.2M in stock awards, accounting for 57% of the total pay in 2023.
Barrow also received $318.7K in non-equity incentive plan, $598.8K in salary and $13.7K in other compensation.
Rankings
In 2023, Robert Barrow's compensation ranked 474th out of 2,790 executives tracked by ExecPay. In other words, Barrow earned more than 83.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 474 out of 2,790 | 83rd |
Division Manufacturing | 274 out of 1,530 | 82nd |
Major group Chemicals And Allied Products | 191 out of 869 | 78th |
Industry group Drugs | 188 out of 832 | 77th |
Industry Medicinal Chemicals and Botanical Products | 4 out of 17 | 77th |
Source: SEC filing on April 26, 2024.
Barrow's colleagues
We found two more compensation records of executives who worked with Robert Barrow at Mind Medicine (MindMed) in 2023.